31782408|t|Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion.
31782408|a|BACKGROUND Tourniquet-related complications are a common clinical problem. In the present study, we compared the effects of dexmedetomidine vs. oxycodone in patients undergoing limb ischemia-reperfusion. MATERIAL AND METHODS Fifty-four patients undergoing unilateral lower-extremity surgery under combined spinal and epidural anesthesia were randomly assigned to a control (ischemia-reperfusion, I/R) group, a dexmedetomidine (Dex) group, and an oxycodone (Oxy) group. Tourniquet-induced hemodynamic parameters changes among groups were compared. The serum concentration of malondialdehyde (MDA), superoxide dismutase (SOD), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), fatty acid binding protein 3 (FABP3), endothelin-1 (ET-1), and brain-derived neurotrophic factor (BDNF) were measured using ELISA before anesthesia and at 30 min and at 6 h after tourniquet release. RESULTS In the control group, tourniquet use caused significant increases in systolic arterial pressure (SAP), mean arterial pressure (MAP), diastolic arterial pressure (DAP), and rate-pressure product. Compared with Oxy, Dex significantly decreased heart rate (HR). Both Dex and Oxy lowered SAP compared with the control group. No significant difference was observed in DAP between Dex and Oxy. The levels of MDA, TNF-alpha, IL-6, FABP3, and ET-1 were significantly higher, while the SOD and BDNF were significantly lower compared to baseline in the I/R group, but the variation range of those agents was significantly smaller in the Dex and Oxy groups, and the measured values were comparable between the 2 groups. CONCLUSIONS Compared with Dex, Oxy was not inferior in mitigating tourniquet-induced hyperdynamic response, ameliorating the inflammatory reaction, and protecting remote multiple organs in lower-extremity surgery patients.
31782408	22	37	Dexmedetomidine	Chemical	MESH:D020927
31782408	42	51	Oxycodone	Chemical	MESH:D010098
31782408	55	63	Patients	Species	9606
31782408	75	88	Limb Ischemia	Disease	MESH:D007511
31782408	113	123	Tourniquet	Disease	
31782408	226	241	dexmedetomidine	Chemical	MESH:D020927
31782408	246	255	oxycodone	Chemical	MESH:D010098
31782408	259	267	patients	Species	9606
31782408	279	292	limb ischemia	Disease	MESH:D007511
31782408	338	346	patients	Species	9606
31782408	476	484	ischemia	Disease	MESH:D007511
31782408	512	527	dexmedetomidine	Chemical	MESH:D020927
31782408	529	532	Dex	Chemical	MESH:D020927
31782408	548	557	oxycodone	Chemical	MESH:D010098
31782408	559	562	Oxy	Chemical	MESH:D010098
31782408	676	691	malondialdehyde	Chemical	MESH:D008315
31782408	693	696	MDA	Chemical	MESH:D008315
31782408	699	719	superoxide dismutase	Gene	6647
31782408	721	724	SOD	Gene	6647
31782408	727	754	tumor necrosis factor-alpha	Gene	7124
31782408	756	765	TNF-alpha	Gene	7124
31782408	768	781	interleukin-6	Gene	3569
31782408	783	787	IL-6	Gene	3569
31782408	790	818	fatty acid binding protein 3	Gene	2170
31782408	820	825	FABP3	Gene	2170
31782408	828	840	endothelin-1	Gene	1906
31782408	842	846	ET-1	Gene	1906
31782408	853	886	brain-derived neurotrophic factor	Gene	627
31782408	888	892	BDNF	Gene	627
31782408	969	979	tourniquet	Disease	
31782408	1019	1029	tourniquet	Disease	
31782408	1206	1209	Oxy	Chemical	MESH:D010098
31782408	1211	1214	Dex	Chemical	MESH:D020927
31782408	1261	1264	Dex	Chemical	MESH:D020927
31782408	1269	1272	Oxy	Chemical	MESH:D010098
31782408	1372	1375	Dex	Chemical	MESH:D020927
31782408	1380	1383	Oxy	Chemical	MESH:D010098
31782408	1399	1402	MDA	Chemical	MESH:D008315
31782408	1404	1413	TNF-alpha	Gene	7124
31782408	1415	1419	IL-6	Gene	3569
31782408	1421	1426	FABP3	Gene	2170
31782408	1432	1436	ET-1	Gene	1906
31782408	1474	1477	SOD	Gene	6647
31782408	1482	1486	BDNF	Gene	627
31782408	1541	1543	/R	Disease	MESH:C580424
31782408	1624	1627	Dex	Chemical	MESH:D020927
31782408	1632	1635	Oxy	Chemical	MESH:D010098
31782408	1732	1735	Dex	Chemical	MESH:D020927
31782408	1737	1740	Oxy	Chemical	MESH:D010098
31782408	1772	1782	tourniquet	Disease	
31782408	1791	1803	hyperdynamic	Disease	
31782408	1831	1843	inflammatory	Disease	MESH:D007249
31782408	1919	1927	patients	Species	9606
31782408	Positive_Correlation	MESH:D008315	MESH:D010098
31782408	Positive_Correlation	MESH:D010098	3569
31782408	Negative_Correlation	MESH:D020927	MESH:D007511
31782408	Positive_Correlation	MESH:D010098	2170
31782408	Positive_Correlation	MESH:C580424	3569
31782408	Positive_Correlation	MESH:D020927	6647
31782408	Positive_Correlation	MESH:D010098	1906
31782408	Comparison	MESH:D010098	MESH:D020927
31782408	Positive_Correlation	MESH:D020927	2170
31782408	Positive_Correlation	MESH:D008315	MESH:D020927
31782408	Positive_Correlation	MESH:D010098	627
31782408	Positive_Correlation	MESH:D020927	3569
31782408	Positive_Correlation	MESH:D020927	627
31782408	Positive_Correlation	MESH:D008315	MESH:C580424
31782408	Negative_Correlation	MESH:C580424	627
31782408	Negative_Correlation	MESH:D010098	MESH:D007249
31782408	Positive_Correlation	MESH:D010098	7124
31782408	Positive_Correlation	MESH:D020927	1906
31782408	Positive_Correlation	MESH:C580424	7124
31782408	Positive_Correlation	MESH:C580424	1906
31782408	Negative_Correlation	MESH:D010098	MESH:D007511
31782408	Positive_Correlation	MESH:C580424	2170
31782408	Negative_Correlation	MESH:D010098	MESH:C580424
31782408	Negative_Correlation	MESH:C580424	6647
31782408	Positive_Correlation	MESH:D020927	7124
31782408	Positive_Correlation	MESH:D010098	6647

